True dat! Not only has the data fromPDD and RS been delayed but so has the roll out of 4 trials. Could it be that this “soup” has new learned data that has new endpoints which are being designed by the company and the Fda in these 4 new trials. It would follow the pattern of learning, the leaps and bounds, trial over trial always building, learning, and implementation of applied knowledge.
No worries here about timing as the “B team” said it best, “ everyday of nonews moves us closer to data release!” When “it” comes its gonna be a whopper cause we all know TGD cant sit on bad data aannnnnd…good data from the PDD and early RS adult has been shared!
Market Data 
Markets 
AI
